Bishal Gyawali Was Honored with ASCO Fellowship for Outstanding Contributions to Oncology

The Ontario Institute for Cancer Research (OICR) is a leading research institute dedicated to advancing cancer research and improving patient outcomes. Established in 2005, OICR focuses on translating scientific discoveries into real-world applications in cancer prevention, diagnosis, and treatment.

OICR operates through several key research programs, including cancer genomics, cancer biology, and clinical trials, which aim to uncover the mechanisms of cancer and develop innovative therapies. The institute emphasizes collaboration, bringing together researchers, clinicians, and industry partners to drive impactful research.

In addition to its research initiatives, OICR is committed to training the next generation of cancer researchers, providing educational programs and mentorship opportunities. By fostering a collaborative environment and supporting groundbreaking work, OICR plays a crucial role in enhancing cancer care and contributing to advancements in oncology both in Ontario and globally.

Ontario Institute for Cancer Research (OICR) shared on their X page:

“OICR congratulates Dr. Bishal Gyawali on being named as a Fellow of the American Society of Clinical Oncology! This honour recognizes exceptional contributions to the field of oncology and dedication to advancing cancer care. We are proud to support Dr. Gyawali’s work.”

Bishal Gyawali, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives.

Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.

Bishal Gyawali shared a post on X:

“Thank you, Ontario Institute for Cancer Research (OICR) for supporting researchers like us. Proud to be an OICR Clinician Scientist and represent Ontario at International platforms like ASCO. Thank you ASCO for the honor and recognition.